Apoptosis and chemoresistance in human ovarian cancer: is Xiap a determinant?

J Li1, H Sasaki, Y L Sheng

  • 1Department of Obstetrics and Gynaecology and Department of Cellular and Molecular Medicine, University of Ottawa, Loeb Health Research Institute, The Ottawa Hospital (Civic Campus), Canada.

Insights

Cisplatin chemotherapy triggers apoptosis in ovarian cancer by altering cell death and survival gene expression. Targeting Xiap (X-linked inhibitor of apoptosis protein) may overcome chemoresistance.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Cisplatin is a key chemotherapy agent for epithelial ovarian cancer (EOC).
  • Chemoresistance remains a significant challenge in EOC treatment.
  • The balance between cell death and cell survival genes influences treatment response.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying cisplatin-induced apoptosis in EOC cells.
  • To identify key regulatory genes involved in chemoresistance.
  • To explore Xiap as a potential therapeutic target for overcoming cisplatin resistance.

Main Methods:

  • Analysis of gene expression changes in EOC cells treated with cisplatin.
  • Focus on the roles of Xiap (X-linked inhibitor of apoptosis protein), Fas/FasL, caspase-3, MDM2, and FAK.
  • Exploration of gene therapy strategies involving Xiap antisense and P53.

Main Results:

  • Cisplatin treatment suppresses Xiap expression and upregulates the Fas/FasL system in EOC cells.
  • These changes activate caspase-3 and lead to cleavage of MDM2 and FAK.
  • Imbalance in these gene expressions favors chemoresistance.

Conclusions:

  • Suppressed Xiap and activated Fas/FasL are crucial in cisplatin-induced apoptosis.
  • Xiap dysregulation contributes to chemoresistance in EOC.
  • Targeting Xiap, potentially with P53 modulation, offers a novel therapeutic strategy for chemoresistant ovarian cancer.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...